305 related articles for article (PubMed ID: 11902578)
1. Assessing TP53 status in human tumours to evaluate clinical outcome.
Soussi T; Béroud C
Nat Rev Cancer; 2001 Dec; 1(3):233-40. PubMed ID: 11902578
[TBL] [Abstract][Full Text] [Related]
2. p53 family update: p73 and p63 develop their own identities.
Irwin MS; Kaelin WG
Cell Growth Differ; 2001 Jul; 12(7):337-49. PubMed ID: 11457731
[No Abstract] [Full Text] [Related]
3. Another p53 Doppelgänger?
Kaelin WG
Science; 1998 Jul; 281(5373):57-8. PubMed ID: 9679018
[No Abstract] [Full Text] [Related]
4. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
Bougeard G; Limacher JM; Martin C; Charbonnier F; Killian A; Delattre O; Longy M; Jonveaux P; Fricker JP; Stoppa-Lyonnet D; Flaman JM; Frébourg T
J Med Genet; 2001 Apr; 38(4):253-7. PubMed ID: 11370630
[No Abstract] [Full Text] [Related]
5. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
6. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
Stein T; Crighton D; Boyle JM; Varley JM; White RJ
Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
[TBL] [Abstract][Full Text] [Related]
7. p63 and p73: old members of a new family.
Marin MC; Kaelin WG
Biochim Biophys Acta; 2000 May; 1470(3):M93-M100. PubMed ID: 10799748
[No Abstract] [Full Text] [Related]
8. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
Senoo M; Matsumura Y; Habu S
Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
[TBL] [Abstract][Full Text] [Related]
9. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
Courtois S; Caron de Fromentel C; Hainaut P
Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
[TBL] [Abstract][Full Text] [Related]
10. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
11. p53 and its younger siblings.
Knight RA
Cell Death Differ; 1999 Dec; 6(12):1143. PubMed ID: 10637427
[No Abstract] [Full Text] [Related]
12. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.
Glazko GV; Koonin EV; Rogozin IB
Biochim Biophys Acta; 2004 Aug; 1679(2):95-106. PubMed ID: 15297143
[TBL] [Abstract][Full Text] [Related]
13. p53 leans on its siblings.
Urist M; Prives C
Cancer Cell; 2002 May; 1(4):311-3. PubMed ID: 12086844
[TBL] [Abstract][Full Text] [Related]
14. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
[TBL] [Abstract][Full Text] [Related]
15. TP53 tumor-suppressor gene and human carcinogenesis.
Basset-Séguin N; Molès JP; Mils V; Dereure O; Guilhou JJ
Exp Dermatol; 1993 Jun; 2(3):99-105. PubMed ID: 8162331
[TBL] [Abstract][Full Text] [Related]
16. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Lang GA; Iwakuma T; Suh YA; Liu G; Rao VA; Parant JM; Valentin-Vega YA; Terzian T; Caldwell LC; Strong LC; El-Naggar AK; Lozano G
Cell; 2004 Dec; 119(6):861-72. PubMed ID: 15607981
[TBL] [Abstract][Full Text] [Related]
17. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
[TBL] [Abstract][Full Text] [Related]
18. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
19. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
